nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-194CD835·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.2 Internal medicine·Subfield: Genetics·Basis: Full text·Type: Theoretical or mathematical paper

Understanding the bidirectional relationship between chronic respiratory disease and cardiovascular disease using genetic evidence.

Naesilla et al.Naesilla, Quint, Zuber·2025·Thorax·10.1136/thorax-2024-222908 ↗

Primary claim

Our study found no clear genetic evidence of a bidirectional association between CRD and CVD. These findings suggest that the observed associations in clinical studies may not indicate direct causal effects between the diseases.

Tentative · broad-phenotype MR cannot exclude direct effects amid substantial heterogeneity and unassessed power for null conclusions
In brief

A useful uniform MR update on CRD–CVD comorbidity whose inference against direct causation exceeds what its heterogeneous null estimates establish.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Abstract

BACKGROUND: Chronic respiratory diseases (CRDs) and cardiovascular diseases (CVDs) are leading global health burdens. Despite being common, CRD and CVD comorbidity is often underestimated due to overlapping symptoms and risk factors. Consequently, their relationship remains unclear.

AIMS AND OBJECTIVES: To determine the bidirectional genetic relationship between CRD and CVD and explore smoking and inflammation as potentially shared joint risk factors.

METHODS: We conducted bidirectional Mendelian randomisation (MR) to explore CRD-CVD relationships. Summary statistics from genome-wide association studies were retrieved for chronic obstructive pulmonary disease (COPD), asthma, coronary artery disease (CAD), myocardial infarction (MI), heart failure, atrial fibrillation (AF) and ischaemic stroke (IS). We performed additional analysis including univariable MR for smoking, multivariable MR adjusting for smoking and cis-MR to investigate the role of inflammatory markers.

RESULTS: Our MR analysis found limited genetic evidence of relationships between CRD and CVD, and vice versa. However, a nominally significant genetic association was observed between asthma and an increased risk of AF (OR inverse-variance weighted (ORIVW) 1.036, 95% CI 1.003 to 1.070), remaining weakly significant after adjusting for smoking (ORIVW 1.040, 95% CI 1.008 to 1.074). Genetically predicted lifetime smoking strongly increased all CRD and CVD risk. Additionally, genetically proxied IL6R concentration associated with increased asthma risk and decreased CAD, MI, AF and IS risk, while IL1RN decreased COPD risk but increased CAD and MI risk.

CONCLUSIONS: While we found limited genetic evidence linking CRD and CVD, smoking and inflammatory markers commonly affect both. These findings highlight the complexity of CRD-CVD comorbidities, whose pathophysiology likely does not involve direct causation of each other.

Key Claims

Primary finding · Tentative

Our study found no clear genetic evidence of a bidirectional association between CRD and CVD. These findings suggest that the observed associations in clinical studies may not indicate direct causal effects between the diseases.

broad-phenotype MR cannot exclude direct effects amid substantial heterogeneity and unassessed power for null conclusions

What This Study Adds
Quote verified
Secondary · Tentative

A nominally significant genetic association was observed between asthma and an increased risk of AF (OR 1.036, 95% CI 1.003 to 1.070), remaining weakly significant after adjusting for smoking (OR 1.040, 95% CI 1.008 to 1.074).

nominal uncorrected association with discordant sensitivity estimates and substantial heterogeneity

Abstract, Results
Secondary · Supported

Genetically predicted lifetime smoking strongly increased all CRD and CVD risk.

directionally consistent associations across outcomes, tempered by pleiotropy signals and weaker asthma evidence

Abstract, Results
Quote verified
Secondary · Supported

Genetically proxied IL6R concentration associated with increased asthma risk and decreased CAD, MI, AF and IS risk, while IL1RN decreased COPD risk but increased CAD and MI risk.

FDR-significant cis-MR associations without colocalisation to distinguish shared causal variants from linkage

Abstract, Results, inflammatory markers
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Uniform analysis across major disease pairs

The same bidirectional MR framework is applied across COPD, asthma, CAD, MI, heart failure, AF, and ischaemic stroke, allowing more consistent comparison than separate outcome-specific studies.

↳ Methods, Univariable MR; Introduction, final paragraph

#methodological rigour

Multiple sensitivity estimators are reported

The analysis supplements IVW with MR-Egger, weighted median, MR-PRESSO, and contamination-mixture methods and reports heterogeneity and pleiotropy diagnostics.

↳ Methods, Effect Estimation and Sensitivity Analyses; Results, disease-pair analyses

#positioning

Conflicting prior MR results receive attention

The Discussion compares the asthma–AF and COPD–HF findings with studies using different GWAS sources and instrument thresholds, rather than presenting the estimates in isolation.

↳ Discussion, paragraphs 2–3

Limitations

#reporting

Causal-negative conclusion exceeds the evidence

The Abstract and policy statement infer that direct CRD–CVD causation is absent or unlikely, although the analyses are predominantly null rather than equivalence-based and show substantial heterogeneity.

↳ Abstract, Conclusions; How This Study Might Affect Research, Practice or Policy; Results, COPD and asthma analyses

#methodological rigour

MVMR instrument strength remains under-specified

Instruments were selected only for the primary exposure, and no conditional F-statistics or equivalent multivariable strength diagnostics are reported. This limits confidence in the smoking-adjusted estimates.

↳ Methods, Multivariable MR

#positioning

Acknowledged heterogeneity conflicts with conclusion

The Discussion states that broad diagnoses may obscure subtype-specific associations, but the headline framing still treats direct causation as absent or unlikely across CRD and CVD.

↳ Discussion, paragraph beginning “Two reasons may explain”; Abstract, Conclusions

Does this match your read? Add your assessment ↓

Nabu Commentary

The updated GWAS sources, uniform bidirectional design, and multiple sensitivity estimators support a useful incremental contribution. The main score constraint is inferential: substantial heterogeneity, discordant COPD sensitivity estimates, and no power or equivalence analysis prevent null estimates from establishing that direct causation is absent. The MVMR analysis also lacks conditional instrument-strength reporting, while the inflammatory-marker results remain target-generating without colocalisation. Engagement with conflicting prior studies is substantive, but the final causal-negative framing does not preserve the uncertainty acknowledged in the limitations.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.2±0.2

Contribution
3.3

The study provides an incremental update by applying one bidirectional MR pipeline to two respiratory and five cardiovascular outcomes, followed by smoking and inflammatory-marker analyses. It addresses conflicting prior MR findings but does not decisively resolve them.

Introduction, final paragraph; Discussion, paragraphs comparing prior asthma–AF and COPD–HF studies

Our use of updated GWAS sources and a uniform analytical pipeline

Methodological Rigour
3.3

The analysis states the principal MR assumptions and uses IVW, MR-Egger, weighted median, MR-PRESSO, and contamination-mixture estimators. Confidence is reduced by absent conditional instrument-strength assessment for MVMR, no power analysis for causal-negative conclusions, substantial heterogeneity, and cis-MR without colocalisation.

Methods, Univariable MR and Multivariable MR; Results, COPD and asthma analyses; Discussion, inflammation and limitations

genetic instruments were reselected solely from the primary exposure of interest

Reporting
3.4

The article is structured coherently and labels the asthma–AF association as nominal and unlikely to survive multiple testing. Its abstract and policy-facing language nevertheless converts limited evidence into an asserted absence or unlikelihood of direct causation.

Abstract, Conclusions; What This Study Adds; How This Study Might Affect Research, Practice or Policy

highlights the absence of a direct causal relationship

Positioning
2.8

The Discussion engages conflicting asthma–AF and COPD–HF studies and connects several limitations to interpretation. The contextual strength is capped because the acknowledged possibility that broad phenotypes obscure true associations conflicts with the stronger causal-negative conclusion.

Discussion, prior-study comparisons and paragraph beginning “Two reasons may explain”; Abstract, Conclusions

the wide range of phenotypes may obscure true associations

Reliability

Caveats4 of 4 checks


Results checkClean

The reported numbers and statistics are consistent with the stated results.

Reporting and transparencyNoted

The data availability statement gives incompatible descriptions of public access, leaving the availability of the analysis data unclear.

Conflict of interest: not stated · Ethics approval: not stated · Preregistration: not stated · Data availability: declared · Code availability: not stated

Reference IntegrityClean

39 of 39 checkable references verified

48 references in manuscript 9 have no canonical index record — counted, but not index-checkable 1 reference confirmed by manual review

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Generic health relevance
Type of advanceConceptual
Route to useNot stated
AdvanceAdvances
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessFoundational
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The evidence is observational genetic analysis of summary statistics, with no intervention or effect shown working in any controlled or applied setting.

The paper's stated impact section calls only for further studies to uncover mechanisms, naming no real-world use of these findings beyond research.

Pathway

Researchers and prevention guideline developers would use the null causal findings to redirect comorbidity management toward shared risk factors such as smoking cessation.

Barrier

The null Mendelian randomisation findings carry heterogeneity, pleiotropy and European-ancestry limitations, and require replication and mechanistic confirmation before informing practice.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Genome-wide meta-analysis of quantitatively measured generalized anxiety symptoms in individuals of European ancestry

    Skelton, Mitchell, Assary, et al. · 2026 · Clinical medicine

    Primary claim

    We identified 80 independent genome-wide significant variants within 74 loci, 39 of which were newly associated with anxiety.

    Well-supported
    Evidence Score
    4.0±0.2
    Reliability
    Caveats
  2. Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes

    Rossi, Sportelli, Kikidis, et al. · 2026 · Clinical medicine

    Primary claim

    Applying this framework to Psychiatric Genomics Consortium wave 3 genotypes identified 766 genes associated with schizophrenia

    Tentative
    Evidence Score
    3.0±0.2
    Reliability
    Caveats
  3. Shared proteomic landscape between arteriosclerosis and cardiovascular endpoints: a Mendelian randomization and observational study integrating AlphaFold3 for structural prediction

    Huang, Meena, Achtari, et al. · 2026 · Clinical medicine

    Primary claim

    We prioritized 10 proteins potentially causally associated with both the arteriosclerotic/atherosclerotic markers and cardiovascular events.

    Supported
    Evidence Score
    3.3±0.2
    Reliability
    Caveats

How the rubric works →